BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18374101)

  • 1. Effects of histone deacetylase inhibitor SAHA on effector and FOXP3+regulatory T cells in rhesus macaques.
    Johnson J; Pahuja A; Graham M; Hering B; Hancock WW; Bansal-Pakala P
    Transplant Proc; 2008 Mar; 40(2):459-61. PubMed ID: 18374101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAHA, an HDAC inhibitor, synergizes with tacrolimus to prevent murine cardiac allograft rejection.
    Zhang X; Han S; Kang Y; Guo M; Hong S; Liu F; Fu S; Wang L; Wang QX
    Cell Mol Immunol; 2012 Sep; 9(5):390-8. PubMed ID: 22922441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid.
    Reilly CM; Mishra N; Miller JM; Joshi D; Ruiz P; Richon VM; Marks PA; Gilkeson GS
    J Immunol; 2004 Sep; 173(6):4171-8. PubMed ID: 15356168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving allogeneic islet transplantation by suppressing Th17 and enhancing Treg with histone deacetylase inhibitors.
    Sugimoto K; Itoh T; Takita M; Shimoda M; Chujo D; SoRelle JA; Naziruddin B; Levy MF; Shimada M; Matsumoto S
    Transpl Int; 2014 Apr; 27(4):408-15. PubMed ID: 24410777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of suberoylanilide hydroxamic acid (SAHA) administration on the residual virus pool in a model of combination antiretroviral therapy-mediated suppression in SIVmac239-infected indian rhesus macaques.
    Del Prete GQ; Shoemaker R; Oswald K; Lara A; Trubey CM; Fast R; Schneider DK; Kiser R; Coalter V; Wiles A; Wiles R; Freemire B; Keele BF; Estes JD; Quiñones OA; Smedley J; Macallister R; Sanchez RI; Wai JS; Tan CM; Alvord WG; Hazuda DJ; Piatak M; Lifson JD
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6790-806. PubMed ID: 25182644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-responsive gene expression in suberoylanilide hydroxamic acid-treated resting CD4+ T cells.
    Reardon B; Beliakova-Bethell N; Spina CA; Singhania A; Margolis DM; Richman DR; Woelk CH
    AIDS; 2015 Nov; 29(17):2235-44. PubMed ID: 26258524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suberoylanilide hydroxamic acid induces limited changes in the transcriptome of primary CD4(+) T cells.
    Beliakova-Bethell N; Zhang JX; Singhania A; Lee V; Terry VH; Richman DD; Spina CA; Woelk CH
    AIDS; 2013 Jan; 27(1):29-37. PubMed ID: 23221426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4
    Peixoto TV; Carrasco S; Botte DAC; Catanozi S; Parra ER; Lima TM; Ugriumov N; Soriano FG; de Mello SBV; Rodrigues CM; Goldenstein-Schainberg C
    Adv Rheumatol; 2019 Jul; 59(1):30. PubMed ID: 31340848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors.
    Lucas JL; Mirshahpanah P; Haas-Stapleton E; Asadullah K; Zollner TM; Numerof RP
    Cell Immunol; 2009; 257(1-2):97-104. PubMed ID: 19358983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled release of an HDAC inhibitor for reduction of inflammation in dry eye disease.
    Ratay ML; Balmert SC; Bassin EJ; Little SR
    Acta Biomater; 2018 Apr; 71():261-270. PubMed ID: 29526828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proliferation of CD4+ CD25+ regulatory T cells of rat by different cytokines in vitro].
    Wang ZH; Zhu JY; Li T; Leng XS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(12):844-7. PubMed ID: 18756991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Histone-Deacetylase-Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase-13 Activity.
    Duncan HF; Smith AJ; Fleming GJ; Partridge NC; Shimizu E; Moran GP; Cooper PR
    J Cell Physiol; 2016 Apr; 231(4):798-816. PubMed ID: 26264761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suberoylanilide Hydroxamic Acid Attenuates Autoimmune Arthritis by Suppressing Th17 Cells through NR1D1 Inhibition.
    Kim DS; Min HK; Kim EK; Yang SC; Na HS; Lee SY; Choi JW; Jung KA; Kwok SK; Park SH; Cho ML
    Mediators Inflamm; 2019; 2019():5648987. PubMed ID: 31780863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the antioxidant effects of different histone deacetylase inhibitors (HDACis) on human lens epithelial cells (HLECs) after UVB exposure.
    Qiu X; Rong X; Yang J; Lu Y
    BMC Ophthalmol; 2019 Feb; 19(1):42. PubMed ID: 30717701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits anti-inflammatory activities through induction of mitochondrial damage and apoptosis in activated lymphocytes.
    Shi ZJ; Ouyang DY; Zhu JS; Xu LH; He XH
    Int Immunopharmacol; 2012 Apr; 12(4):580-7. PubMed ID: 22369900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase inhibitors promote mice corneal allograft survival through alteration of CD4+ effector T cells and induction of Foxp3+ regulatory T cells.
    Guo X; Jie Y; Ren D; Zeng H; Zhang Y; He Y; Pan Z
    Cell Immunol; 2012; 277(1-2):8-13. PubMed ID: 22776176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichostatin A promotes the generation and suppressive functions of regulatory T cells.
    Doñas C; Fritz M; Manríquez V; Tejón G; Bono MR; Loyola A; Rosemblatt M
    Clin Dev Immunol; 2013; 2013():679804. PubMed ID: 23737814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines.
    Leoni F; Zaliani A; Bertolini G; Porro G; Pagani P; Pozzi P; Donà G; Fossati G; Sozzani S; Azam T; Bufler P; Fantuzzi G; Goncharov I; Kim SH; Pomerantz BJ; Reznikov LL; Siegmund B; Dinarello CA; Mascagni P
    Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2995-3000. PubMed ID: 11867742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. All-trans retinoic acid inhibits type 1 diabetes by T regulatory (Treg)-dependent suppression of interferon-gamma-producing T-cells without affecting Th17 cells.
    Van YH; Lee WH; Ortiz S; Lee MH; Qin HJ; Liu CP
    Diabetes; 2009 Jan; 58(1):146-55. PubMed ID: 18984738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.